He Jingjing, Shen Mengjie, Ye Xin, Ren Xiuhong, Chen Ke, Zhang Jiangxu, Fan Weijun, Wang Zhongmin, Xu Yin
Department of Minimally Invasive Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.
Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Lung Cancer Institute, Jinan, China.
Asia Pac J Oncol Nurs. 2024 Sep 10;11(11):100591. doi: 10.1016/j.apjon.2024.100591. eCollection 2024 Nov.
Co-ablation system therapy is currently in its early stages of application in tumor treatment in China. The associated protocols for perioperative management are not yet well-developed and suffer from a lack of corresponding guidelines or consensus. This study aims to improve the quality of clinical treatment and nursing care and to standardize perioperative management for patients with liver tumors undergoing co-ablation system therapy. The Committee of Ablation Therapy in Oncology, China Anti-Cancer Association, and the Committee of Interventional Perioperative, Interventional Physician Branch of the Chinese Medical Doctor Association organized medical and nursing experts in China. Based on the clinical practice of co-ablation system therapy in China and the relevant domestic literature, an expert consensus regarding perioperative management was developed. The expert consensus includes the key points of perioperative management, prevention and care of complications, discharge guidance, and follow-up management for patients who have undergone co-ablation system therapy of liver tumors. The consensus on the perioperative management of co-ablation system therapy for liver tumors has finally been formulated, providing a reference and application for medical personnel in relevant fields based on hospital and patient conditions in clinical work.
在我国,联合消融系统疗法目前正处于肿瘤治疗应用的早期阶段。围手术期管理的相关方案尚未完善,缺乏相应的指南或共识。本研究旨在提高临床治疗和护理质量,规范接受联合消融系统疗法的肝肿瘤患者的围手术期管理。中国抗癌协会肿瘤消融治疗专业委员会和中国医师协会介入医师分会围手术期介入专业委员会组织了国内医学和护理专家。基于我国联合消融系统疗法的临床实践及国内相关文献,制定了关于围手术期管理的专家共识。该专家共识涵盖了接受肝肿瘤联合消融系统疗法患者的围手术期管理要点、并发症的预防与护理、出院指导及随访管理。最终形成了肝肿瘤联合消融系统疗法围手术期管理的共识,为临床工作中相关领域的医务人员根据医院和患者情况提供参考与应用。